Our conjecture was further supported by the increased mRNA and protein levels of GCLC and GCLM and the mRNA expression of several necessary GSH metabolism-related catalytic enzymes in the IUGR + Zn group. The gene discussed is GCLM; the disease is fetal growth restriction.